Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PhRMA

Executive Summary

House Commerce Committee majority counsel Lori Wall will join the Pharmaceutical Research & Manufacturers of America as a policy director. Wall worked with the Oversight Subcommittee on its investigation of ordering pharmaceuticals over the Internet

You may also be interested in...



PhRMA policy

Former Exec Director-Strategic Affairs & Economic Analysis Ann-Marie Lynch is new VP-policy for the Pharmaceutical Research & Manufacturers of America, reporting to Exec VP Judith Bello. Lynch succeeds Steve Cole, who is leaving the association. Lynch joined PhRMA in January from the staff of Rep. Thomas' (R-Calif.) Ways & Means/Health Subcommittee (1"The Pink Sheet" Jan. 10, p. 16). The PhRMA policy team is adding another House Republican staffer: former Commerce/Oversight Subcommittee majority counsel Lori Wall starts as director of policy Sept. 11 (2"The Pink Sheet" Sept. 4, In Brief). Cole joined PhRMA in 1997 from the Federation of American Health Systems

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

UsernamePublicRestriction

Register

OM004078

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel